Hematology/Oncology Grand Rounds
2006-2007
- 2000-2001 | 2001-2002 | 2002-2003 | 2003-2004 | 2004-2005 | 2005-2006
- 2006-2007 | 2007-2008 | 2008-2009 | 2009-2010
- Topic Index (2001-present)
- Speaker Index (2001-present)
| Friday | Speaker | Title |
| Hematology Core Lectures | ||
| July 7, 2006 | Morey Blinder | Peripheral blood smears (PowerPoint) |
| July 14 | Monica Bessler | Bone marrow failure (PowerPoint/HTML) |
| July 21 | Morey Blinder | Anemia (PowerPoint) |
| July 28 | Doug Lublin | Transfusion (PowerPoint) |
| August 4 | Morey Blinder | Bleeding disorders (PowerPoint) |
| August 11 | Evan Sadler | Von Willebrand disease and TTP (PowerPoint) |
| August 18 | Chuck Eby | Laboratory testing for venous thromboembolism risk assessment (PowerPoint) |
| August 25 | Doug Tollefsen | Anticoagulants and HIT (PowerPoint) |
| September 1 | Morey Blinder | Diagnostic hematology: monoclonal gammopathies and hemoglobin disorders (PowerPoint) |
| Grand Rounds | ||
| September 8 | Josh Field Tanya Wildes Rich Walgren |
Protocol design and submission (PowerPoint) |
| September 15 | Mark Pomerantz (Dana-Farber Cancer Institute) |
Hormones, genes and prostate cancer risk |
| September 22 | Kerry Williams | Medullary renal carcinoma - the seventh sickle cell nephropathy (PowerPoint) |
| Stuart Kornfeld | Molecular origins of chronic myeloproliferative disorders (PowerPoint) | |
| September 29 | CANCELED | |
| October 6 | James Mosley | Malignant peripheral nerve sheath tumor (PowerPoint) |
| Mark Schroeder | Mysteries of the mantle zone: good is bad and bad is good except in mantle cell (PowerPoint) | |
| October 13 | Mike Martin | Management of a Jehovah's Witness with TTP (PowerPoint) |
| Daniel Morgensztern | Carcinoma of unknown primary (PowerPoint) | |
| October 20 | John Welch | APL and ATRA: sure it works, but how? (PowerPoint) |
| Cynthia Ma | Adjuvant chemotherapy for estrogen receptor positive breast cancer: more questions than answers (PowerPoint) | |
| October 27 | Julie Kanter (Pediatrics) | Malignant mesenchymoma: a review of the literature and treatment options (PowerPoint/HTML) |
| Priya Gopalan | Neoadjuvant endocrine therapy in breast cancer (PowerPoint) | |
| November 3 | Jeff Bednarski (Pediatrics) | CNS germinomas, diabetes insipidus, and chemotherapy: challenges in management (PowerPoint) |
| Morey Blinder | Unexplained iron deficiency anemia (PowerPoint) | |
| November 10 | Richard Walgren | Epigenetic changes in MDS (PowerPoint) |
| Matt Walter | Detection of deletions and amplifications in primary AML genomes | |
| November 17 | Boone Goodgame | Tailored toxic therapy: identifying platinum resistance (PowerPoint) |
| Phil Majerus | The association of ITP with TTP in a young woman (PowerPoint) | |
| December 1 | Todd Fehniger | Regulatory T cells in anti-tumor immunity (PowerPoint) |
| John DiPersio | Review of Washington University mobilization database (PowerPoint) | |
| December 8 | ASH | |
| December 15 | Coy Heldermon | Her-2 or not (PowerPoint) |
| Mike Martin | Pemetrexed in thoracic malignancies (PowerPoint) | |
| January 5, 2007 | Nima Sharifi (National Cancer Institute) |
Prostate cancer: from TGF-beta resistance to androgen independence |
| January 12 | Kerry Williams | Irinotecan: can we predict toxicity? (PowerPoint) |
| John Welch | CML: goal oriented therapy (PowerPoint) | |
| January 19 | Tom Fong | Copper deficiency and myelodysplasia (PowerPoint) |
| January 26 | David Threadgill (UNC Chapel Hill) |
EGFR-inhibition therapies are dependent upon genetic and environmental context |
| February 2 | Jeff Bednarski (Pediatrics) | Thymic carcinoma: should biology dictate therapy? (PowerPoint) |
| Kathy Ponder | New treatments for iron overload (PowerPoint) | |
| February 9 | Tanya Wildes | Targeted therapy in relapsed Hodgkin's disease (PowerPoint) |
| David Kuperman | Induction therapy for squamous cell cancer of the head and neck (PowerPoint) | |
| February 16 | Mark Schroeder | Steroid refractory acute GVHD (PowerPoint) |
| Elaine Majerus | Familial thrombocytopenias (PowerPoint) | |
| February 23 | Julie Kanter (Pediatrics) | The clinical implications of treating patients with Li-Fraumeni syndrome (PowerPoint) |
| James Mosley | Management of mechanical complications of lung cancer (PowerPoint) | |
| March 2 | Coy Heldermon | Neoadjuvant chemotherapy of breast cancer (PowerPoint) |
| Dan Link | Pathogenesis of severe congenital neutropenia (PowerPoint) | |
| March 9 | Boone Goodgame | Prognostic value of FDG-PET for early stage carcinomas (PowerPoint) |
| Doug Tollefsen | Drug-induced thrombocytopenia (PowerPoint) | |
| March 16 | Priya Gopalan | Ovarian cancer (PowerPoint) |
| Monica Bessler | Complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria: results from the TRIUMPH/SEPHARD study (PowerPoint) | |
| March 23 | Todd Fehniger | Emerging therapies for fludarabine-refractory CLL (PowerPoint) |
| Donald Lombardi | Treatment and biology of HER-2/neu gene amplified breast cancer | |
| March 30 | Mike Martin | How Andy Warhol treated myelodysplastic syndrome (PowerPoint) |
| Ben Tan | Treatment of liver-only metastatic colorectal cancer (PowerPoint) | |
| April 6 | Richard Walgren | Pharmacogenomic studies of human treatment-related MDS and AML (PowerPoint) |
| Gerry Linette | Cancer immunotherapy update (PowerPoint) | |
| April 13 | Tanya Wildes | Physical activity and cancer risk (PowerPoint) |
| Evan Sadler | Stroke in a nineteen year old girl with sickle cell disease (PowerPoint) | |
| April 20 | Kerry Williams | Burkitt's lymphoma mimicking a gynecological malignancy (PowerPoint) |
| Kathy Weilbaecher | G-CSF enhances bone tumor growth in mice in an osteoclast-dependent manner (PowerPoint) | |
| April 27 | David Kuperman | Autologous stem cell transplants for solid tumors (PowerPoint) |
| Steven Sorscher | Rationale for cancer gene therapy: si quaeris peninsulam amoenam circumpice (PowerPoint) | |
| May 4 | Tom Fong | Tumors of the small bowel (PowerPoint) |
| Caron Rigden | Her2 positive breast cancer: beyond trastuzumab (PowerPoint) | |
| May 11 | John Welch | Post-chemotherapy nausea (PowerPoint) |
| Rama Suresh | Breast MRI (PowerPoint) | |
| May 18 | Mark Schroeder | Cancer stem cells: a review and implications for novel therapeutic approaches (PowerPoint) |
| Chuck Eby | Thrombotic complications during treatment of bleeding in hemophiliacs (PowerPoint) | |
| May 25 | James Mosley | Hormone-refractory prostate cancer: current trends and future directions (PowerPoint) |
| Paula Fracasso | Concurrent cetuximab, cisplatin, and radiation therapy in advanced cervical cancer (PowerPoint) | |
| June 1 | ASCO |
- Updated: July 1, 2009
